Literature DB >> 25536006

Relation between oxidative stress and climacteric symptoms in early postmenopausal women.

A Cagnacci1, M Cannoletta, F Palma, M Bellafronte, C Romani, B Palmieri.   

Abstract

OBJECTIVES: To evaluate the relation between climacteric symptoms or other risk factors for cardiovascular disease and oxidative status of postmenopausal women.
METHODS: Cross-sectional investigation performed at the outpatient service for the menopause at the University Hospital, on 50 apparently healthy women in physiological postmenopause. The whole-blood free oxygen radical test (FORT), free oxygen radical defence (FORD), age, months since menopause, weight, body mass index, waist circumference, waist-to-hip ratio, estradiol, lipids, glucose, insulin, insulin resistance (glucose/insulin and HOMA-IR), and fibrinogen were evaluated. The Greene Climacteric Scale with its subscales was used to evaluate climacteric symptoms. The pulsatility index, an index of downstream blood flow resistance, was determined for both the internal carotid artery and the brachial artery.
RESULTS: The waist-to-hip ratio (r = 0.540; p = 0.0001), estradiol (r = 0.548; p = 0.0004) and waist circumference (r = 0.345; p = 0.02) were independently related to blood FORT. The score in the Greene vasomotor subscale was the only parameter independently related to blood FORD (r = 0.554; p = 0.0001). FORT was not related to the artery pulsatility index, while FORD was negatively related to the pulsatility index of both the internal carotid (r = 0.549; p = 0.0001) and the brachial (r = 0.484; p = 0.0001) arteries. DISCUSSION: In postmenopausal women, abdominal adiposity and hypoestrogenism increase oxidative stress. Climacteric symptoms, particularly vasomotor symptoms, markedly reduce antioxidant defences. Lower antioxidant defences are associated with higher resistance to blood flow in the great arteries. In women early after the menopause, visceral fat, hypoestrogenism and climacteric symptoms may increase the risk for cardiovascular disease.

Entities:  

Keywords:  ANTIOXIDANT; CAROTID ARTERY; FREE RADICALS; HOT FLUSH; LIPID; MENOPAUSE; PULSATILITY INDEX

Mesh:

Substances:

Year:  2015        PMID: 25536006     DOI: 10.3109/13697137.2014.999659

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  6 in total

Review 1.  Vasomotor symptoms: natural history, physiology, and links with cardiovascular health.

Authors:  R C Thurston
Journal:  Climacteric       Date:  2018-02-02       Impact factor: 3.005

2.  Association of physical fitness with health-related quality of life in early postmenopause.

Authors:  N Moratalla-Cecilia; A Soriano-Maldonado; P Ruiz-Cabello; M M Fernández; E Gregorio-Arenas; P Aranda; V A Aparicio
Journal:  Qual Life Res       Date:  2016-04-16       Impact factor: 4.147

3.  Association between hot flashes severity and oxidative stress among Mexican postmenopausal women: A cross-sectional study.

Authors:  Martha A Sánchez-Rodríguez; Mariano Zacarías-Flores; Alicia Arronte-Rosales; Víctor Manuel Mendoza-Núñez
Journal:  PLoS One       Date:  2019-09-24       Impact factor: 3.240

4.  Combination of Red Clover and Hops Extract Improved Menopause Symptoms in an Ovariectomized Rat Model.

Authors:  Mi Ran Kim; Hyun Jin Kim; Su Hyun Yu; Bo Su Lee; Se Yeong Jeon; Jeong Jun Lee; Young Chul Lee
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-23       Impact factor: 2.629

5.  Improvement of oxidative stress status by lipoprotein apheresis in Chinese patients with familial hypercholesterolemia.

Authors:  Jun Wen; Qian Dong; Geng Liu; Ying Gao; Xiao-Lin Li; Jing-Lu Jin; Jian-Jun Li; Yuan-Lin Guo
Journal:  J Clin Lab Anal       Date:  2019-12-20       Impact factor: 2.352

6.  The Effects of Sinapic Acid on the Development of Metabolic Disorders Induced by Estrogen Deficiency in Rats.

Authors:  Maria Zych; Ilona Kaczmarczyk-Sedlak; Weronika Wojnar; Joanna Folwarczna
Journal:  Oxid Med Cell Longev       Date:  2018-06-04       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.